We are live on ! Find out more
BJDX icon

Bluejay Diagnostics

4 hedge funds and large institutions have $143K invested in Bluejay Diagnostics in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.09% less ownership

Funds ownership: 1.66%1.57% (-0.09%)

16% less capital invested

Capital invested by funds: $170K → $143K (-$27.6K)

20% less funds holding

Funds holding: 54 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DS
1
DRW Securities
Illinois
$90.8K +$90.2K +14,942 New
SM
2
Sabby Management
Florida
$45K -$100K -16,601 -69%
TRCT
3
Tower Research Capital (TRC)
New York
$6.76K +$3.28K +544 +96%
Bank of America
4
Bank of America
North Carolina
$18 +$12 +2 +200%
UBS Group
5
UBS Group
Switzerland
-$764 -111 Closed
Citigroup
6
Citigroup
New York
-$415 -60 Closed

BJDX Hedge Fund Activity: Q3 2025 in Review

4 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q3 2025, worth a combined $143K — down 16% from $170K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BJDX and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.

The largest buyer was DRW Securities, opening a new position worth an estimated $90.2K. The largest seller was Sabby Management, cutting an estimated $100K.

  • 4 institutional investors held Bluejay Diagnostics (BJDX) as of Q3 2025, down from 5 in Q2 2025.
  • Funds reported $143K of Bluejay Diagnostics stock for Q3 2025, down 16% quarter-over-quarter.
  • 1 fund opened new Bluejay Diagnostics positions in Q3 2025 and 2 closed out, a net change of -1 holder.
  • The largest Bluejay Diagnostics buyer in Q3 2025 was DRW Securities, an estimated $90.2K added.
  • The largest Bluejay Diagnostics seller in Q3 2025 was Sabby Management, an estimated $100K sold.

Based on aggregated 13F filings for Q3 2025.